HHM Wealth Advisors’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-141
Closed -$522 878
2025
Q3
$522 Buy
141
+2
+1% +$5 ﹤0.01% 825
2025
Q2
$272 Buy
139
+13
+10% +$27 ﹤0.01% 837
2025
Q1
$222 Sell
126
-12
-9% -$27 ﹤0.01% 896
2024
Q4
$368 Buy
138
+10
+8% +$26 ﹤0.01% 940
2024
Q3
$294 Buy
+128
New +$390 ﹤0.01% 749

Other funds holding NUVB

HHM Wealth Advisors's NUVB Position: Q4 2025 in Review

HHM Wealth Advisors sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 141 shares — an estimated $522 sold.

HHM Wealth Advisors first reported a position in NUVB in Q3 2024 and held it in 5 quarters. The position peaked at $522 in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • HHM Wealth Advisors reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • HHM Wealth Advisors sold 141 Nuvation Bio shares in Q4 2025, an estimated $522.
  • HHM Wealth Advisors first reported a position in Nuvation Bio in Q3 2024 and held it in 5 quarters.
  • HHM Wealth Advisors's Nuvation Bio position peaked at $522 in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on HHM Wealth Advisors's 13F filing for Q4 2025, filed 22 Jan 2026.